Clinical Report: Exploring the Link Between Homicide and Zonisamide

Overview

Revise to emphasize the significance of the case in the context of existing literature.

Background

Cerebral cavernous malformations (CCMs) can lead to focal epilepsy, necessitating long-term management with ASMs. While second and third generation ASMs are preferred for their tolerability, their psychiatric side effects, including aggression and suicidal ideation, are often overlooked. Understanding these risks is crucial for optimizing patient care and minimizing morbidity associated with epilepsy management.

Data Highlights

No numerical data was presented in the article.

Key Findings

• This is the first case report documenting homicidal ideation as an adverse effect of zonisamide.
• Psychiatric adverse effects (PAEs) of ASMs include depression, anxiety, and aggression.
• Patients with pre-existing psychiatric conditions are at higher risk for PAEs when using ASMs.
• Forced normalization can complicate treatment decisions in epilepsy care.
• Close monitoring is essential during ASM titration and after discontinuation to manage psychiatric risks.

Clinical Implications

Clinicians should be vigilant about the potential for psychiatric adverse effects when prescribing ASMs, particularly zonisamide. Regular screening for psychiatric symptoms and careful monitoring during treatment can help mitigate risks and improve patient outcomes.

Conclusion

The association between zonisamide and homicidal ideation underscores the importance of recognizing and addressing psychiatric side effects in patients receiving ASMs. Further research is needed to better understand these risks and inform clinical practice.

Related Resources & Content

1. Frontiers in Psychiatry, 2026 -- Homicide and Zonisamide: A Review of the Literature and Illustrative Case Report on Second and Third Generation Antiseizure Medications and Psychiatric Effects
2. Neurology, 2025 -- Seizures and Epilepsy in Patients With Untreated Cerebral Cavernous Malformations
3. PubMed -- Psychiatric and behavioural side effects of antiseizure medications in epilepsy
4. Drug Safety — Zopiclone-Related Fatal Intoxications: An Emerging Concern?
5. BMC Psychiatry (Springer) — Effect of olanzapine on changes in serum complement factors levels in patients with first-episode schizophrenia
6. Drugs - Real World Outcomes — Evaluating the Association of Lithium Carbonate with Clozapine Side Effects, Including Neutropenia: Insights from the Japanese Adverse Drug Event Report Database
7. BMC Psychiatry (Springer) — Dual-target mechanisms of olanzapine in bipolar disorder: a network pharmacology and molecular docking study revealing phase-specific regulation of longevity and PI3K-Akt pathways
8. Seizures and Epilepsy in Patients With Untreated Cerebral Cavernous Malformations | Neurology
9. Psychiatric and behavioural side effects of antiseizure medications in epilepsy - PubMed
10. Frontiers | "Homicide and Zonisamide": A Review of the Literature and Illustrative Case Report on Second and Third Generation Antiseizure Medications and Psychiatric Effects